TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7977853

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic hypoglycemia (H; 2.5 mmol/l)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyperinsulinemic euglycemia (E; 4.5 mmol/l)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control (P; saline)
Number of subjects: 0
Study: 2531510

Group type: EXPERIMENTAL
Intervention: ISDN (standard release formulation) 40 mg administered 6 times daily (240 mg total)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ISDN (40 mg) administered 4 times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous administration of glycerol trinitrate (3 mg/h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral ISDN (standard release formulation) administered 4-6 times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrate therapy providing constant doses over time (e.g. I.V. nitroglycerin)
Number of subjects: 0
Study: 1119423

Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fructose
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (Glucose)
Number of subjects: 8
Study: 31323455

Group type: EXPERIMENTAL
Intervention: 1 financial stressor
Number of subjects: 22048

Group type: EXPERIMENTAL
Intervention: 2 financial stressors
Number of subjects: 22048

Group type: EXPERIMENTAL
Intervention: 3 or more financial stressors
Number of subjects: 22048
Study: 27939227

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl 4 g/day
Number of subjects: 215
Study: 26186450

Group type: EXPERIMENTAL
Intervention: S. frutescens 1,200 mg twice daily
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 23385606

Group type: EXPERIMENTAL
Intervention: Imageless computer-assisted surgery (CAS)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional implantation
Number of subjects: 75
Study: 21504887

Group type: EXPERIMENTAL
Intervention: Counseling sessions for mothers (1 face-to-face, 2 by telephone) and fathers (3 by telephone), educational pamphlet, smoke-free home sticker
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Counseling sessions for mothers and fathers
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study: 19897434

Group type: EXPERIMENTAL
Intervention: TEFI (Transient Expiratory Flow Interruptions) using a device with an inspiratory line and a valve interrupting flow at 4 Hz
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group with the valve kept open
Number of subjects: 30
Study: 17658455

Group type: EXPERIMENTAL
Intervention: Physostigmine 0.5%
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Physostigmine 1%
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Physostigmine 2%
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 15193203

Group type: EXPERIMENTAL
Intervention: Planned vaginal birth
Number of subjects: 64

Group type: COMPARATOR
Intervention: Planned Caesarean delivery
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Not sure about participation
Number of subjects: 64
Study: 11675816

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 44
Study: 9286131

Group type: EXPERIMENTAL
Intervention: Multidisciplinary crisis intervention for psychiatric patients referred to the emergency department.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short-term psychiatric inpatient treatment in another hospital.
Number of subjects: 0
Study: 8329826

Group type: EXPERIMENTAL
Intervention: Low-dose GHRH(1-29)-NH2 (LD group; n = 15) at 30 micrograms/kg/day s.c. in three daily doses
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: High-dose GHRH(1-29)-NH2 (HD group; n = 12) at 60 micrograms/kg/day s.c. in three daily doses
Number of subjects: 43

Group type: COMPARATOR
Intervention: Growth hormone (GH group; n = 16) at 0.1 IU/kg/day s.c. once daily
Number of subjects: 43
Study: 3329851

Group type: EXPERIMENTAL
Intervention: FD group (154 micrograms fentanyl plus 5.5 mg droperidol i.v.)
Number of subjects: 87

Group type: COMPARATOR
Intervention: FV group (127 micrograms fentanyl plus 6.7 mg Valium)
Number of subjects: 87
Study: 31626000

Group type: EXPERIMENTAL
Intervention: Education Centered Medical Home (ECMH)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Mentored Individual Preceptorship (IP)
Number of subjects: 329
Study: 29034740

Group type: EXPERIMENTAL
Intervention: Gamiguibi-tang (GGBT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 30
Study: 27644633

Group type: EXPERIMENTAL
Intervention: Ginger (500 mg ginger powder, twice a day for 3 days)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 23892521

Group type: EXPERIMENTAL
Intervention: Microencapsulated ferric saccharate (MFS)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ferrous sulfate (FS)
Number of subjects: 17
Study: 21464158

Group type: EXPERIMENTAL
Intervention: sorafenib
Number of subjects: 69

Group type: COMPARATOR
Intervention: sorafenib + interferon‐α (IFN‐α)
Number of subjects: 69
Study: 21609911

Group type: EXPERIMENTAL
Intervention: Betahistine dihydrochloride treatment after Epley's maneuver (EM)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no treatment with betahistine after EM)
Number of subjects: 90
Study: 18313995

Group type: EXPERIMENTAL
Intervention: Oseltamivir phosphate preparation 1
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oseltamivir phosphate preparation 2
Number of subjects: 24
Study: 15800557

Group type: EXPERIMENTAL
Intervention: Precooked Russet potatoes
Number of subjects: 22

Group type: COMPARATOR
Intervention: Day-cooked Russet potatoes
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Boiled white potatoes
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Various potato varieties and cooking methods
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Instant mashed potatoes
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Boiled red potatoes
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Roasted California white potatoes
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Baked US Russet potatoes
Number of subjects: 22
Study: 12448388

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (vertical banded gastroplasty, Roux‐en‐Y gastric bypass, distal RYGBP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Non-operated morbidly obese controls
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (all types)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 45
Study: 10319352

Group type: EXPERIMENTAL
Intervention: Treatment (three different methods)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (16 patients observed without treatment)
Number of subjects: 65
Study: 9172005

Group type: EXPERIMENTAL
Intervention: Test preparation A (furosemide, 500 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Reference preparation B (furosemide, 500 mg)
Number of subjects: 15
Study: 1479049

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6398127

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MPN) 375 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Low-dose metoclopramide (MCP) 60 mg
Number of subjects: 90
Study: 30547350

Group type: EXPERIMENTAL
Intervention: Insomnia (defined by insomnia severity index score ≥ 10)
Number of subjects: 603

Group type: COMPARATOR
Intervention: Non-insomnia group
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Men with insomnia
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Women with insomnia
Number of subjects: 603
Study: 28988340

Group type: EXPERIMENTAL
Intervention: Core decompression plus BMAC implantation
Number of subjects: 46

Group type: COMPARATOR
Intervention: Core decompression plus saline injection
Number of subjects: 46
Study: 26338095

Group type: EXPERIMENTAL
Intervention: Tabalumab 120 mg every two weeks (120 Q2W)
Number of subjects: 1164

Group type: EXPERIMENTAL
Intervention: Tabalumab 120 mg every four weeks (120 Q4W)
Number of subjects: 1164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1164

Group type: EXPERIMENTAL
Intervention: Tabalumab (both dosing regimens)
Number of subjects: 1164

Group type: COMPARATOR
Intervention: Tabalumab and placebo
Number of subjects: 1164
Study: 24991973

Group type: EXPERIMENTAL
Intervention: 5-session HIV/HCV/STI prevention intervention (risk reduction: RR)
Number of subjects: 600

Group type: COMPARATOR
Intervention: 5-session Wellness Promotion (WP) intervention
Number of subjects: 600
Study: 21944671

Group type: EXPERIMENTAL
Intervention: Miglitol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Voglibose
Number of subjects: 50
Study: 20022995

Group type: EXPERIMENTAL
Intervention: Comfortable gait speed (CGS) improvement
Number of subjects: 283
Study: 18184932

Group type: EXPERIMENTAL
Intervention: Robotic training (n = 11)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intensive movement protocol (n = 10)
Number of subjects: 21
Study: 16925195

Group type: EXPERIMENTAL
Intervention: 30 mg intravenous ketorolac (Toradol), 0.25% subcutaneous bupivacaine (Marcaine) with epinephrine along the incision, and 0.25% bupivacaine in the rectus fascia
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 20
Study: 12647074

Group type: EXPERIMENTAL
Intervention: Pylorus-preserving Whipple
Number of subjects: 150000

Group type: COMPARATOR
Intervention: Classical Whipple
Number of subjects: 150000

Group type: COMPARATOR
Intervention: Extended lymph node dissection
Number of subjects: 150000
Study: 10860185

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 8880843

Group type: EXPERIMENTAL
Intervention: Tonic experimental muscle pain
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham pain
Number of subjects: 20
Study: 1387778

Group type: EXPERIMENTAL
Intervention: Inocoterone 10% solution
Number of subjects: 126

Group type: COMPARATOR
Intervention: Vehicle solution
Number of subjects: 126
Study: 6830136

Group type: EXPERIMENTAL
Intervention: Op-Site skin closure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interrupted silk sutures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subcuticular nylon
Number of subjects: 0
Study: 30583763

Group type: EXPERIMENTAL
Intervention: SafeWalker® robotic walking aid
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 20
Study: 30357272

Group type: EXPERIMENTAL
Intervention: Recombinant alkaline phosphatase 1.6 mg/kg
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Recombinant alkaline phosphatase 0.4 mg/kg
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Recombinant alkaline phosphatase 0.8 mg/kg
Number of subjects: 301
Study: 26400845

Group type: EXPERIMENTAL
Intervention: Educational nursing program over 9 months
Number of subjects: 61
Study: 24438438

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AEx)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (LCh)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Aerobic exercise + Low carbohydrate diet (AEx + LCh)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control
Number of subjects: 200
Study: 23390781

Group type: EXPERIMENTAL
Intervention: Combination 5-fluoruracil (5-FU) with cisplatinum
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Single 5-fluoruracil (5-FU) regimen
Number of subjects: 88

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Cisplatinum with 5-FU
Number of subjects: 88

Group type: COMPARATOR
Intervention: 5-FU regimen
Number of subjects: 88
Study: 19439098

Group type: EXPERIMENTAL
Intervention: Percutaneous Laser Disc Decompression (PLDD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional open discectomy
Number of subjects: 0
Study: 17469917

Group type: EXPERIMENTAL
Intervention: Place training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 0
Study: 16237467

Group type: EXPERIMENTAL
Intervention: Surgical treatment for gastric cancer
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Distal gastrectomy
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 137
Study: 11888754

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg/24 h P.O. + 2x0.5 mg digoxin IV on the operating day + digoxin 0.25 mg P.O. + metoprolol 100 mg P.O. on the first postoperative day until discharge
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Amiodarone 1200 mg IV/24 h (300 mg bolus dose/1 h post-operation, then 450 mg/24 h IV and 600 mg/day P.O. until discharge)
Number of subjects: 241

Group type: COMPARATOR
Intervention: No antiarrhythmic prophylaxis
Number of subjects: 241
Study: 10468706

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lactose
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Nitric oxide production
Number of subjects: 9
Study: 8597006

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA) at 2.5 mg/kg/d
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA) at 5.0 mg/kg/d
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA)
Number of subjects: 10
Study: 1817786

Group type: EXPERIMENTAL
Intervention: Minimum information on local anesthesia
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Basic information on local anesthesia
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Extended information on local anesthesia
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 240
Study: 7156449

Group type: EXPERIMENTAL
Intervention: 25% N2O‐‐75% O2
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 50% N2O‐‐50% O2
Number of subjects: 9

Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 9
Study: 31079146

Group type: EXPERIMENTAL
Intervention: Group Sinovac
Number of subjects: 14

Group type: COMPARATOR
Intervention: Group CAMS
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both Groups
Number of subjects: 14
Study: 29921405

Group type: EXPERIMENTAL
Intervention: Automatic reposition treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual reposition treatment
Number of subjects: 60
Study: 26838074

Group type: EXPERIMENTAL
Intervention: XueBiJing injection (intravenous infusion)
Number of subjects: 0
Study: 24467711

Group type: EXPERIMENTAL
Intervention: Isolated Roux loop pancreaticojejunostomy (IRPJ)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pancreaticogastrostomy (PG)
Number of subjects: 90
Study: 23271772

Group type: EXPERIMENTAL
Intervention: Active monitoring
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Radical surgery
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Radical radiotherapy
Number of subjects: 1500
Study: 19356901

Group type: EXPERIMENTAL
Intervention: Instrumental variable analysis
Number of subjects: 0
Study: 17172550

Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intensive traditional therapy
Number of subjects: 23
Study: 15678729

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate infusion (5 mg kg(‐1) bolus followed by 500 mg h(‐1) infusion for 24 h)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (saline infusion in the same volumes for 24 h)
Number of subjects: 50
Study: 12201932

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 9619458

Group type: COMPARATOR
Intervention: Gamma nail
Number of subjects: 170

Group type: COMPARATOR
Intervention: Compression hip screw (CHS)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Dynamic hip screw with a laterally mounted trochanteric stabilizing plate (DHS/TSP)
Number of subjects: 170
Study: 7649315

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 104
Study: 2696196

Group type: EXPERIMENTAL
Intervention: Intracavernous noradrenaline (10 micrograms per hour)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 420135

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (155 cal and 20 g of protein per day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 0
Study: 31126835

Group type: EXPERIMENTAL
Intervention: Remote Ischaemic Preconditioning (RIPC)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 98
Study: 27898575

Group type: EXPERIMENTAL
Intervention: Treatment for early syphilis
Number of subjects: 369

Group type: COMPARATOR
Intervention: Male sex
Number of subjects: 369

Group type: COMPARATOR
Intervention: Baseline RPR titers ≤ 1:32
Number of subjects: 369
Study: 26108088

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal spray (FPNS) 200 mcg once daily
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 682

Group type: COMPARATOR
Intervention: FPNS placebo
Number of subjects: 682

Group type: COMPARATOR
Intervention: Cetirizine placebo
Number of subjects: 682
Study: 23648948

Group type: EXPERIMENTAL
Intervention: BSS+ (Behavioral Support Sessions plus bupropion therapy)
Number of subjects: 1955

Group type: EXPERIMENTAL
Intervention: BSS (Behavioral Support Sessions)
Number of subjects: 1955

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1955
Study: 21369950

Group type: EXPERIMENTAL
Intervention: Lornoxicam 16 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 19402296

Group type: EXPERIMENTAL
Intervention: Vitamin D injection (600,000 IU)
Number of subjects: 82
Study: 17367443

Group type: EXPERIMENTAL
Intervention: Topical verapamil hydrochloride 15% gel applied twice daily for 3 months, followed by open label for 6 months.
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (placebo) not specified in detail.
Number of subjects: 57
Study: 15599680

Group type: EXPERIMENTAL
Intervention: Sodium selenite
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 11563779

Group type: EXPERIMENTAL
Intervention: Suramin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mitomycin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Without Mitomycin
Number of subjects: 10
Study: 9039201

Group type: EXPERIMENTAL
Intervention: Butenafine 1% cream applied once daily for 2 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: Vehicle control applied once daily for 2 weeks
Number of subjects: 93
Study: 7892940

Group type: EXPERIMENTAL
Intervention: Ferroplex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Feramide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conferon
Number of subjects: 0
Study: 3587619

Group type: EXPERIMENTAL
Intervention: Lecithin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29572629

Group type: EXPERIMENTAL
Intervention: 25-gauge core biopsy needle with a stylet (S+)
Number of subjects: 114

Group type: COMPARATOR
Intervention: 25-gauge core biopsy needle without a stylet (S-)
Number of subjects: 114
Study: 27306272

Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioral Therapy for Insomnia (GT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Internet Cognitive Behavioral Therapy for Insomnia (IT)
Number of subjects: 62
Study: 25261882

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23511116

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 19

Group type: COMPARATOR
Intervention: Nontreatment
Number of subjects: 19
Study: 28555208

Group type: EXPERIMENTAL
Intervention: One-piece implants (OPI)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Two-piece implants (TPI)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both OPI and TPI
Number of subjects: 38
Study: 18779548

Group type: EXPERIMENTAL
Intervention: Medical Management intervention (including naltrexone and acamprosate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical Management intervention
Number of subjects: 0
Study: 17157118

Group type: EXPERIMENTAL
Intervention: Olopatadine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Epinastine
Number of subjects: 66
Study: 14588129

Group type: EXPERIMENTAL
Intervention: Letter plus follow-up letter
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Letter plus follow-up phone call
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Phone call plus follow-up phone call
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cervical cancer screening outreach (Control)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cervical cancer screening outreach with letter reminders
Number of subjects: 100
Study: 10920316

Group type: EXPERIMENTAL
Intervention: Planned cesarean delivery
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Other cesarean delivery
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Vaginal delivery
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: CD4 count <200/microL
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: CD4 count >=200/microL
Number of subjects: 497
Study: 8933483

Group type: EXPERIMENTAL
Intervention: Exercise training (4 sessions per week at 60-80% of maximal heart rate)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (6 men)
Number of subjects: 16
Study: 1579326

Group type: EXPERIMENTAL
Intervention: Group I (missing pills on days 1-4)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Group II (missing pills on days 3-6)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Group III (missing pills on days 6-9)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All groups (combined results)
Number of subjects: 15